Suparna C. Clasen
- Hematology top 10%
- Multiple Myeloma Research and Treatments 3
-
- Chemotherapy-induced cardiotoxicity and mitigation 10
-
- Cancer Treatment and Pharmacology 5
- Peptidase Inhibition and Analysis 2
-
- Protein Degradation and Inhibitors 2
-
- Chemotherapy-induced organ toxicity mitigation 2
-
- Polymer Nanocomposite Synthesis and Irradiation 2
-
- Cardiac Imaging and Diagnostics 2
Suparna C. Clasen
13 papers receiving 375 citations
Peers
Comparison fields: 5 of 64
- Hematology 106
- Cardiology and Cardiovascular Medicine 198
- Oncology 179
- Genetics 26
- Molecular Biology 131
Countries citing papers authored by Suparna C. Clasen
This map shows the geographic impact of Suparna C. Clasen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suparna C. Clasen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suparna C. Clasen more than expected).
Fields of papers citing papers by Suparna C. Clasen
This network shows the impact of papers produced by Suparna C. Clasen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suparna C. Clasen. The network helps show where Suparna C. Clasen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Suparna C. Clasen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2023 | 0 | |
| 4 | 2023 | 4 | |
| 5 | 2022 | 4 | |
| 6 | 2022 | 6 | |
| 7 | 2021 | 11 | |
| 8 | 2020 | 11 | |
| 9 | 2019 | 62 | |
| 10 | 2019 | 1 | |
| 11 | 2018 | 9 | |
| 12 | 2018 | 5 | |
| 13 | 2017 | 45 | |
| 14 | 2017 | 7 | |
| 15 | 2017 | 200 | |
| 16 | 2017 | 13 |
About Suparna C. Clasen
Suparna C. Clasen is a scholar working on Cardiology and Cardiovascular Medicine, Hematology and Oncology, having authored 16 papers that have together received 378 indexed citations. Recurring topics across this work include Chemotherapy-induced cardiotoxicity and mitigation (10 papers), Cancer Treatment and Pharmacology (5 papers), Multiple Myeloma Research and Treatments (3 papers), Chemotherapy-induced organ toxicity mitigation (2 papers), Polymer Nanocomposite Synthesis and Irradiation (2 papers), Peptidase Inhibition and Analysis (2 papers), Cardiac Imaging and Diagnostics (2 papers) and Protein Degradation and Inhibitors (2 papers). The work is most often cited by research in Hematology (106 citations), Cardiology and Cardiovascular Medicine (198 citations) and Oncology (179 citations). Suparna C. Clasen has collaborated with scholars based in United States. Frequent co-authors include Bonnie Ky, Rupal O’Quinn, Joseph R. Carver, Adam Waxman, Dan T. Vogl, Edward A. Stadtmauer, Adam D. Cohen, Alfred L. Garfall, Brendan M. Weiss and Wei‐Ting Hwang. Their work appears in journals such as Journal of Clinical Oncology, Current Oncology Reports, JACC CardioOncology, International Journal of Radiation Oncology*Biology*Physics and Current Opinion in Cardiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.